Therefore, in this review, the role ofinhibited autophagy is discussed with specific RNAs targeting Beclin-1 and LC3 genes in breast cancer.
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Autophagy is a catabolic pathway meaning “self-eating” that facilitates nutrient recycling from damaged and aged organellesand other impaired cellular components through lysosomal degradation.
📊
Temel Bulgular & Veri:Whereas, it is very importantto define the role of autophagy as an effective treatment strategy in breast cancer cells.
💡
Sonuç & Katkı:Therefore, in this review, the role ofinhibited autophagy is discussed with specific RNAs targeting Beclin-1 and LC3 genes in breast cancer.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Abstract
Autophagy is a catabolic pathway meaning “self-eating” that facilitates nutrient recycling from damaged and aged organellesand other impaired cellular components through lysosomal degradation. Regulation of this process has been associatedwith the development of cancer. It can play different roles at different tumors and developmental stages of tumors. In breastcancer, similarly, autophagy functions as a mechanism promoting survival or leading to death. Whereas, it is very importantto define the role of autophagy as an effective treatment strategy in breast cancer cells. Therefore, in this review, the role ofinhibited autophagy is discussed with specific RNAs targeting Beclin-1 and LC3 genes in breast cancer.
🔖
Bu Makaleye Atıf Yap
YILMAZ, S. G., HAMURCU, Z., NURDİNOV, N., ÇINAR, V., GÜLER, A., KÖKÇÜ, N. D. (2022). LC3 and Beclin-1 as Markers of Autophagic Activityin Breast Cancer. Erciyes Medical Journal, Cilt: 43 - Sayı: 4, 333–336. https://ajindex.com/articles/502247
Mizushima N. The exponential growth of autophagy-related research: From the humble yeast to the Nobel Prize. FEBS Lett 2017; 591(5): 681–9
Ozpolat B, Benbrook DM. Targeting autophagy in cancer management strategies and developments. Cancer Manag Res 2015; 7: 291–9
Mele L, Del Vecchio V, Liccardo D, Prisco C, Schwerdtfeger M, Robinson N, et al. The role of autophagy in resistance to targeted therapies. Cancer Treat Rev 2020; 88: 102043
Li X, He S, Ma B. Autophagy and autophagy-related proteins in cancer. Mol Cancer 2020; 19(1): 12
Zhou Y, Rucker EB 3rd, Zhou BP. Autophagy regulation in the development and treatment of breast cancer. Acta Biochim Biophys Sin (Shanghai) 2016; 48(1): 60–74
Tang H, Sebti S, Titone R, Zhou Y, Isidoro C, Ross TS, et al. Decreased BECN1 mRNA expression in human breast cancer is associated with estrogen receptor-negative subtypes and poor prognosis. EBioMedicine 2015; 2(3): 255–63
Li Z, Chen B, Wu Y, Jin F, Xia Y, Liu X. Genetic and epigenetic silencing of the beclin 1 gene in sporadic breast tumors. BMC Cancer 2010; 10: 98
Cicchini M, Chakrabarti R, Kongara S, Price S, Nahar R, Lozy F, et al. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. Autophagy 2014; 10(11): 2036–52
Chang SJ, Ou-Yang F, Tu HP, Lin CH, Huang SH, Kostoro J, et al. Decreased expression of autophagy protein LC3 and stemness (CD44+/ CD24-/low) indicate poor prognosis in triple-negative breast cancer. Hum Pathol 2016; 48: 48–55
Ueno T, Saji S, Sugimoto M, Masuda N, Kuroi K, Sato N, et al. Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy. BMC Cancer 2016; 16: 230
Akar U, Chaves-Reyez A, Barria M, Tari A, Sanguino A, Kondo Y, et al. Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells. Autophagy 2008; 4(5): 669–79
Chittaranjan S, Bortnik S, Dragowska WH, Xu J, Abeysundara N, Leung A, et al. Autophagy inhibition augments the anticancer effects of epirubicin treatment in anthracycline-sensitive and resistant triple-negative breast cancer. Clin Cancer Res 2014; 20(12): 3159–73
Zhao H, Yang M, Zhao J, Wang J, Zhang Y, Zhang Q. High expression of LC3B is associated with progression and poor outcome in triple-negative breast cancer. Med Oncol 2013; 30(1): 475